Literature DB >> 23229877

Severe adult burn survivors. What information about skin allografts?

Sonia Gaucher1, Nathalie Duchange, Mohamed Jarraya, Jocelyne Magne, Jean-Michel Rochet, Jean Stéphanazzi, Christian Hervé, Grégoire Moutel.   

Abstract

During the acute phase of a severe burn, surgery is an emergency. In this situation, human skin allografts constitute an effective temporary skin substitute. However, information about the use of human tissue can not be given to the patients because most of the allografted patients are unconscious due to their injury. This study explored the restitution of information on skin donation to patients who have been skin allografted and who have survived their injury. A qualitative study was conducted due to the limited number of patients in ability to be interviewed according to our medical and psychological criteria. 12 patients who had been treated between 2002 and 2008 were interviewed. Our results show that 10 of them ignored that they had received skin allografts. One of the two patients who knew that they had received allografts knew that skin had been harvested from deceased donor. All patients expressed that there is no information that should not be delivered. They also expressed their relief to have had the opportunity to discuss their case and at being informed during their interview. Their own experience impacted their view in favor of organ and tissue donation.

Entities:  

Mesh:

Year:  2012        PMID: 23229877      PMCID: PMC4882397          DOI: 10.1007/s10561-012-9350-0

Source DB:  PubMed          Journal:  Cell Tissue Bank        ISSN: 1389-9333            Impact factor:   1.522


  26 in total

1.  The 2000 Clinical Research Award. Describing and predicting distress and satisfaction with life for burn survivors.

Authors:  D R Patterson; J T Ptacek; F Cromes; J A Fauerbach; L Engrav
Journal:  J Burn Care Rehabil       Date:  2000 Nov-Dec

2.  Family impact greatest: predictors of quality of life and psychological adjustment in pediatric burn survivors.

Authors:  Markus A Landolt; Sandra Grubenmann; Martin Meuli
Journal:  J Trauma       Date:  2002-12

Review 3.  Burn scar assessment: a systematic review of different scar scales.

Authors:  Nele Brusselaers; Ali Pirayesh; Henk Hoeksema; Jozef Verbelen; Stijn Blot; Stan Monstrey
Journal:  J Surg Res       Date:  2010-06-16       Impact factor: 2.192

4.  Long-term outcome of children surviving massive burns.

Authors:  R L Sheridan; M I Hinson; M H Liang; A F Nackel; D A Schoenfeld; C M Ryan; J L Mulligan; R G Tompkins
Journal:  JAMA       Date:  2000-01-05       Impact factor: 56.272

Review 5.  Meta-analysis of early excision of burns.

Authors:  Yee Siang Ong; Miny Samuel; Colin Song
Journal:  Burns       Date:  2006-01-18       Impact factor: 2.744

6.  Comparison of serial debridement and autografting and early massive excision with cadaver skin overlay in the treatment of large burns in children.

Authors:  D N Herndon; D H Parks
Journal:  J Trauma       Date:  1986-02

7.  Do burn patients need burn specific multidisciplinary outpatient aftercare: research results.

Authors:  N E Van Loey; A W Faber; L A Taal
Journal:  Burns       Date:  2001-03       Impact factor: 2.744

8.  Application of rehabilitation ethics to a selected burn patient population's perspective.

Authors:  Luke P Brewster; Barry K Bennett; Richard L Gamelli
Journal:  J Am Coll Surg       Date:  2006-08-22       Impact factor: 6.113

9.  Our Clinical Experience using Cryopreserved Cadaveric Allograft for the Management of Severe Burns.

Authors:  P See; T T Phan; J J Chua; C Song; K C Tan; S T Lee
Journal:  Cell Tissue Bank       Date:  2001       Impact factor: 1.522

10.  Transplant recipients' conceptions of three key phenomena in transplantation: the organ donation, the organ donor, and the organ transplant.

Authors:  Margareta A Sanner
Journal:  Clin Transplant       Date:  2003-08       Impact factor: 2.863

View more
  1 in total

Review 1.  Novel pharmacotherapy for burn wounds: what are the advancements.

Authors:  Michael R Hamblin
Journal:  Expert Opin Pharmacother       Date:  2018-12-05       Impact factor: 3.889

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.